BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15551306)

  • 1. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
    Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
    Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas.
    Xie Y; Zong P; Wang W; Liu D; Li B; Wang Y; Hu J; Ren Y; Qi Y; Cui X; Chen Y; Liu C; Li F
    Exp Mol Pathol; 2015 Jun; 98(3):446-54. PubMed ID: 25773680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
    Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
    Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
    PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.
    Choi N; Son DS; Song I; Lee HS; Lim YS; Song MS; Lim DS; Lee J; Kim H; Kim J
    Int J Cancer; 2005 Jul; 115(4):575-81. PubMed ID: 15700308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor RASSF1A in human carcinogenesis: an update.
    Dammann R; Schagdarsurengin U; Seidel C; Strunnikova M; Rastetter M; Baier K; Pfeifer GP
    Histol Histopathol; 2005 Apr; 20(2):645-63. PubMed ID: 15736067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas.
    Kawaguchi K; Oda Y; Saito T; Takahira T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2005 Apr; 36(4):357-63. PubMed ID: 15891996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.